Skip to Content

GreenLight Biosciences Holdings

Merger

  • Date:
  • 5/30/2023
  • Company Name:
  • GreenLight Biosciences Holdings
  • Stock Symbol:
  • GRNA
  • Company Name - Buyer:
  • Fall Line Capital, LLC
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 5/30/2023

Case Finder

Locate any case using the tools below.

NEW YORK, May 30, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of GreenLight Biosciences Holdings (NASDAQ: GRNA) (“GreenLight”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Fall Line Capital, LLC (“Fall Line”).

On May 30, 2023, GreenLight announced that it had entered into an agreement to be acquired by Fall Line in a $45.5 million all-cash deal. Pursuant to the merger agreement, Fall Line to acquire all of the outstanding shares of common stock of GreenLight other than certain excluded shares, for $0.30 per share. The deal is expected to close in the third quarter of 2023.

Bragar Eagel & Squire is concerned that GreenLight's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for GreenLight's stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in GreenLight Biosciences Holdings. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: